DOXYCYCLINE HYCLATE TABLETS

The Defense Logistics Agency awarded a delivery order under contract SPE2DX-25-D-9900 to DMS PHARMACEUTICAL GROUP INC, identified by CAGE code 1UNB0, for the supply of 3 units of Doxycycline Hyclate Tablets, identified by NSN 6505016266129, at a total contract value of $18.30. The award was issued on July 14, 2026, with delivery required by the same date to Fort Stewart, Georgia, under FOB Destination terms. The contractor is a certified Small Business, Small Disadvantaged Business, and Women-Owned Business, and all representations and certifications are active in SAM. The contract specifies strict packaging and labeling requirements, including the use of a Transportation Control Number W33RBS61950353 and the National Drug Code 55289-0866-30 to ensure traceability, with shipments prohibited from using parcel post. All items must remain serviceable during transit with no specified preservation standards beyond ensuring integrity for destination inspection. Acceptance occurs at the delivery point by the Contracting Officer or Authorized Government Representative, with compliance tied to the NSN and manufacturer CAGE 0PTU3. Invoicing will be processed through the Defense Finance and Accounting Service in Columbus, Ohio, using specified accounting identifiers. The contracting officer is Lisa Quinn, with administrative support provided by Shairy M. Cartagena. No options, variations, or special requirements such as security clearances, OCI provisions, or detailed inspection criteria beyond conformity to contract specifications are indicated. The contract is structured as a single-line-item, firm-fixed-price delivery order with zero variance allowed in quantity, reflecting a precise, low-value pharmaceutical procurement executed as part of the Department of Defense’s medical supply chain.